Reinbek, Germany

Helga Biergiesser

This inventor holds 2 USPTO granted patents and 1 published patent application and 6 EPO patents. Top assignee: Beiersdorf Ag. Active years: 2013-2017.

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 9.9

ph-index = 1

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2013-2017

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Helga Biergiesser: Innovator in Cosmetic Science

Introduction

Helga Biergiesser is a prominent inventor based in Reinbek, Germany. She has made significant contributions to the field of cosmetic and dermatological preparations. With a total of 2 patents to her name, her work focuses on innovative solutions for skin health.

Latest Patents

Her latest patents include groundbreaking formulations aimed at treating and preventing dry skin. One notable patent is for cosmetic and dermatological preparations containing carnitine, which is designed to actively prevent negative alterations in the physiological homeostasis of healthy skin. Another patent involves glycopyrrolate in cosmetic preparations, specifically focusing on its use in deodorant and antiperspirant formulations.

Career Highlights

Helga Biergiesser is associated with Beiersdorf AG, a leading company in the skincare industry. Her work at Beiersdorf has allowed her to develop and refine her innovative ideas, contributing to the advancement of cosmetic science.

Collaborations

Throughout her career, Helga has collaborated with notable colleagues such as Thomas Nuebel and Wilfried Siefken. These partnerships have fostered a creative environment that encourages the development of new and effective cosmetic solutions.

Conclusion

Helga Biergiesser's contributions to cosmetic science through her patents and collaborations highlight her role as an influential inventor in the industry. Her innovative work continues to impact the field of dermatology and skincare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…